Baron Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Baron Wealth Management's ABBV Position: Q3 2026 in Review
Baron Wealth Management increased its AbbVie (ABBV) stake by 73% in Q3 2026, buying an estimated $644K and bringing the position to 5,936 shares worth $1.55M. The position accounts for 0.4% of the portfolio, ranked #28.
Baron Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 2,286 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Baron Wealth Management held 5,936 shares of AbbVie worth $1.55M as of Q3 2026.
- Baron Wealth Management bought 2,514 AbbVie shares in Q3 2026, an estimated $644K.
- AbbVie made up 0.4% of Baron Wealth Management's portfolio in Q3 2026, its #28 holding.
- Baron Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- 2,286 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.